Explore New Regulatory Insights atHYBRID ANNUAL EDUCATION DAY 2026 Wednesday, May 27, 2026
For Registered Attendees Only
Hybrid Annual Education Day 2026 PRESENTATIONS & MATERIALS
Welcome to the official collection of presentations and materials from CAPRA Hybrid Education Day 2026!
Thank you for being a registered attendee of this year’s event. We were pleased to bring together regulatory professionals, industry leaders, and innovators to explore the latest developments, challenges, and trends shaping the pharmaceutical and life sciences landscape.
We extend our sincere appreciation to our speakers for sharing their expertise and delivering such impactful sessions, and to our Sponsors for their continued support in making this event possible.
You now have exclusive access to the full set of presentations, agenda, attendee list, and Platanium and Gold sponsor information. These resources offer valuable insights, expert perspectives, and practical takeaways to support excellence in regulatory affairs and help you stay informed and ahead in your field.
We encourage you to explore the materials at your convenience and revisit any sessions that were particularly meaningful to your work.
CAPRA Education Day Committee
Annual Education Day Speakers
Click on the speakers' picture to view their bio.
Click on the speakers' picture to view their bio.
Dr. Alysha Croker
Health Canada
Director Strategic Horizontal Policy Division Policy, Planning and International Affairs Directorate
Health Products and Food Branch
Rachel Sampson
Health Canada
Manager, Regulatory Project Management, Office Bureau of Strategic Engagement and Integrated Management Services, Marketed Health Products Directorate | Health Products and Food Branch
Vicki Sabourin
Health Canada
Regulatory Projects Team Lead, Regulatory Project Management Office (RPMO)
Marketed Health Products Directorate (MHPD) | Health Products and Food Branch (HPFB)
Michelle Ciesielski
Health Canada
Manager, Office of Patented Medicines and Liaison (OPML), Office of Submissions and Intellectual Property, Marketed Health Products Directorate | Health Products and Food Branch
Elaha Sarwar
Health Canada
Epidemiologist, Health Products Surveillance and Epidemiology Bureau, Marketed Health Products Directorate
Christiane Grisé-Bard
Health Canada
Associate Director, Bureau of Pharmaceutical Sciences
Pharmaceutical Drugs Directorate
Emilie Falardeau
Health Canada
Associate Director, Centre of Blood, Blood Products and Biotherapeutics
Biologics and Radiopharmaceutical Drugs Directorate
| Time | Topic | Guest Speaker | Duration |
|---|---|---|---|
| 8:00 - 8:50 am | Connect & Collaborate – Hot Breakfast & Networking | 50 mins | |
| 8:50 - 9:00 am | Setting the Stage – Welcoming Remarks | 10 mins | |
9:00 - 10:15 am | Health Canada’s Forward Regulatory Global Regulatory Harmonization – Increased use of regulatory reliance | Dr. Alysha Croker Director Strategic Horizontal Policy Division Policy, Planning and International Affairs Directorate, Health Canada Followed by Questions and Answers | 75 mins |
| 10:15 - 10:30 am | Pause & Recharge – Morning Break and Visit Vendor Booths | 15 mins | |
10:30 - 11:30 am | Post-Market Initiatives and Agile Regulatory Provisions for submitting Risk Management Plans | Rachel Sampson Manager, Regulatory Project Management Office, Bureau of Strategic Engagement and Integrated Management Services, Marketed Health Products Directorate | Health Products and Food Branch, Health Canada Vicki Sabourin A/Regulatory Projects Lead, Health Canada Followed by Questions and Answers | 60 mins |
11:30 - 12:15 pm | Safeguarding Innovation: Understanding Data Protection | Michelle Ciesielski Manager, Office of Patented Medicines and Liaison(OPML) Health Canada Followed by Questions and Answers | 45 mins |
| 12:15 - 1:15 pm | Nourish, Networking and Visit Vendor Booths | 60 mins | |
1:15 - 1:55 pm | Real-World Evidence (RWE) – Integration of patient data from routine care into regulatory decision-making | Elaha Sarwar Epidemiologist, Health Products Surveillance and EpidemiologyBureau, Marketed Health Products Directorate Health Canada Followed by Questions and Answers | 40 mins |
1:55 - 2:35 pm | Complex pharmaceutical health products: Abbreviated New Drug Submission (ANDS) of synthetic peptides where the Canadian Reference Product is a peptide of rDNA origin | Christiane Grisé-Bard Associate Director, Bureau of Pharmaceutical Sciences Health Canada Followed by Questions and Answers | 40 mins |
| 2:35 - 2:50 pm | Reset & Re Engage – Afternoon Break + Visit Vendor Booths | 15 mins | |
2:50 - 3:55 pm | Health Canada’s Management of Workload and Backlog | Emilie Falardeau | 65 mins |
| 3:55 - 4:00 pm | Closing Remarks | CAPRA Education Day Committee | 5 mins |
Agenda
Thank You to Our Sponsors
We extend our sincere gratitude to the generous sponsors of CAPRA Education Day 2026. Your commitment plays a crucial role in bringing together leading experts in Pharmaceuticals and Regulatory Affairs, fostering collaboration, and driving industry innovation. Your support helps ensure the success of this vital knowledge-sharing platform, empowering professionals to exchange insights, explore new developments, and shape the future of Regulatory Affairs.
Thank you for being an integral part of this event and for your continued dedication to advancing the industry!
Click on our sponsors' logos to view more resources.
